| |
|
|
|
scPharmaceuticals Inc.  
|
|
7.545 -0.685 (-0.08%) |
07-09 16:00 |
|
Open: |
8.28 |
Pre close: |
8.23 |
Target:
|
9.42 
|
|
High: |
8.46 |
Low: |
7.38 |
Resistance:
|
8.07
8.78
|
|
Volume: |
76,005 |
Market Cap: |
202M |
Support:
|
6.91
5.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.47
 |
MACD |
MACD(12,26):
|
-0.24 |
|
MA(20): |
7.49 |
Signal(12,26,9): |
-0.32 |
|
MA(100): |
8.55 |
Stochastic Oscillator |
%K(14,3):
|
42.55 |
|
MA(250): |
6.82 |
%D(3): |
30.46 |
|
Average Volume(K) |
3-Month: |
14146
|
52-Week |
High:
|
11.99 |
|
10-Days: |
20249 |
Low: |
3.61 |
|
RSI |
RSI(14):
|
47.29 |
Change(%): |
109.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.650 |
Return on Equity (ttm) |
-50.0 |
Shares Out. (M) |
26.79 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-24.5 |
Shares Float (M) |
7.19 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.97 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.12 |
|
Forward EPS |
-1.770 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
58 |
|
Book Value (p.s.) |
2.630 |
EBITDA (p.s.) |
-1.231 |
P/E |
-4.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-32.07 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-22.69 |
P/CF |
-6.30 |
|
|
|
|
|
|
